ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 622155 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 622155; 2) Community: the network communities that were significantly associated with the response to NSC 622155; 3) Molecule: the relationships between components within communities and NSC 622155; 4) MDR: the compounds that were significantly associated with the NSC 622155.

NSC Compound Enrichment Correlation
NSC 752365 2-[6-(4-Hydroxy-3-methoxy-benzylamino)-hexyl]-benzo[de]isoquinoline-1,3-dione para toluen sulphonate 0.0370731367697097 0.089896202
NSC 757113 METHOTREXATE(+/-) 0.0370731367697097 0.18360527
NSC 127328 Guanidine, 1-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-3-[4-[[2-(diisopropylamino)ethyl]amino]-6-methyl-2-pyrimidinyl]- 0.0370731367697099 0.015130651
NSC 302991 Camptothecin Derivative 0.0370731367697099 0.14846714
NSC 33577 Null 0.0370731367697099 0.23715466
NSC 348401 4-(6-Thioguanine)-7-nitro-2,1,3-benzoxadiazole 0.0370731367697099 0.22052849
NSC 4280 2,9-Dimethylphenanthroline 0.0370731367697099 0.22321066
NSC 607088 Null 0.0370731367697099 0.0044174235
NSC 618296 Null 0.0370731367697099 0.26728663
NSC 625497 Antimony, dibromo(4-thiomorpholinecarbodithioato-S,S')-, (T-4)- 0.0461336314651271 0.16418356
Total:57  Current:43    [First] [Prev] [Next] [Last]